This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 24/1/91    most recent 01.ATV.0000094963.07902.FBv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Malloy, S. I. Articles by Maeda, N. Search for Related Content PubMed PubMed Citation Articles by Malloy, S. I. Articles by Maeda, N. Related Collections Lipid and lipoprotein metabolism Risk Factors Gene expression Genetically altered mice

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:91.)
© 2004 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

Harmful Effects of Increased LDLR Expression in Mice With Human APOE*4 But Not APOE*3

Sudi I. Malloy^*; Michael K. Altenburg^*; Christopher Knouff^*; Lorraine Lanningham-Foster; John S. Parks; Nobuyo Maeda

From the Curriculum in Genetics and Molecular Biology (S.I.M., C.K., N.M.) and Department of Pathology and Laboratory Medicine (M.K.A., N.M.), University of North Carolina, Chapel Hill, and Department of Pathology (L.L.-F., J.S.P.), Wake Forest University School of Medicine, Winston-Salem, NC.

Correspondence to Nobuyo Maeda, Department of Pathology and Laboratory Medicine, University of North Carolina, Chapel Hill, NC 27599. E-mail nobuyo{at}med.unc.edu

Objective— Increased expression of the low-density lipoprotein receptor (LDLR) is generally considered beneficial for reducing plasma cholesterol and atherosclerosis, and its downregulation has been thought to explain the association between apolipoprotein (apo) E4 and increased risk of coronary heart disease in humans.

Methods and Results— Contrary to this hypothesis, doubling Ldlr expression caused severe atherosclerosis with marked accumulation of cholesterol-rich, apoE-poor remnants in mice with human apoE4, but not apoE3, when the animals were fed a Western-type diet. The increased Ldlr expression enhanced in vivo clearance of exogenously introduced remnants in mice with apoE4 only when the remnants were already enriched with apoE4. The rates of nascent lipoprotein production were the same. The adverse effects of increased LDLR suggest a possibility that the receptor can trap apoE4, reducing its availability for the transfer to nascent lipoproteins needed for their rapid clearance, thereby increasing the production of apoE-poor remnants that are slowly cleared. The lower affinity for the LDLR of apoE3 compared with apoE4 could then explain why increased receptor expression had no adverse effects with apoE3.

Conclusions— Our results emphasize the occurrence of important and unexpected interactions between APOE genotype, LDLR expression, and diet.

Key Words: apolipoprotein E isoforms • atherosclerosis • genetic interaction • lipid metabolism • postprandiol hypercholesterolemia

This article has been cited by other articles:

				M. Altenburg, J. Arbones-Mainar, L. Johnson, J. Wilder, and N. Maeda Human LDL Receptor Enhances Sequestration of ApoE4 and VLDL Remnants on the Surface of Hepatocytes but Not Their Internalization in Mice Arterioscler. Thromb. Vasc. Biol., June 1, 2008; 28(6): 1104 - 1110. [Abstract] [Full Text] [PDF]

				M. Altenburg, L. Johnson, J. Wilder, and N. Maeda Apolipoprotein E4 in Macrophages Enhances Atherogenesis in a Low Density Lipoprotein Receptor-dependent Manner J. Biol. Chem., March 16, 2007; 282(11): 7817 - 7824. [Abstract] [Full Text] [PDF]

				D. Lucic, Z. H. Huang, D. S. Gu, M. K. Altenburg, N. Maeda, and T. Mazzone Regulation of macrophage apoE secretion and sterol efflux by the LDL receptor J. Lipid Res., February 1, 2007; 48(2): 366 - 372. [Abstract] [Full Text] [PDF]

				J. Heeren, U. Beisiegel, and T. Grewal Apolipoprotein E Recycling: Implications for Dyslipidemia and Atherosclerosis Arterioscler. Thromb. Vasc. Biol., March 1, 2006; 26(3): 442 - 448. [Abstract] [Full Text] [PDF]

				G. Malek, L. V. Johnson, B. E. Mace, P. Saloupis, D. E. Schmechel, D. W. Rickman, C. A. Toth, P. M. Sullivan, and C. Bowes Rickman Apolipoprotein E allele-dependent pathogenesis: A model for age-related retinal degeneration PNAS, August 16, 2005; 102(33): 11900 - 11905. [Abstract] [Full Text] [PDF]

				S. Zhang, M. H. Picard, E. Vasile, Y. Zhu, R. L. Raffai, K. H. Weisgraber, and M. Krieger Diet-Induced Occlusive Coronary Atherosclerosis, Myocardial Infarction, Cardiac Dysfunction, and Premature Death in Scavenger Receptor Class B Type I-Deficient, Hypomorphic Apolipoprotein ER61 Mice Circulation, June 28, 2005; 111(25): 3457 - 3464. [Abstract] [Full Text] [PDF]

				D Cheng, R Huang, I S Lanham, H M Cathcart, M Howard, E H Corder, and S E Poduslo Functional interaction between APOE4 and LDL receptor isoforms in Alzheimer's disease J. Med. Genet., February 1, 2005; 42(2): 129 - 131. [Abstract] [Full Text] [PDF]

				J. Heeren, T. Grewal, A. Laatsch, N. Becker, F. Rinninger, K.-A. Rye, and U. Beisiegel Impaired Recycling of Apolipoprotein E4 Is Associated with Intracellular Cholesterol Accumulation J. Biol. Chem., December 31, 2004; 279(53): 55483 - 55492. [Abstract] [Full Text] [PDF]

				R. J. Havel and R. L. Hamilton Hepatic Catabolism of Remnant Lipoproteins: Where the Action Is Arterioscler. Thromb. Vasc. Biol., February 1, 2004; 24(2): 213 - 215. [Full Text] [PDF]